Status:
COMPLETED
Effects of Cardiopulmonary Rehabilitation in Participants With Post-COVID 19 Syndrome.
Lead Sponsor:
Centro Universitário Augusto Motta
Conditions:
Post- COVID-19 Syndrome
Exercises
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
COVID-19 is an emerging pandemic disease caused by severe acute respiratory syndrome (SARS-CoV-2). Although the majority of patients infected with SARS-CoV-2 are asymptomatic or have mild symptoms, so...
Detailed Description
This is a randomized, controlled, double-blind treatment trial with a 1:1 allocation ratio. Participants: Patients will be recruited at the Central Hospital of the Military Police and in the speciali...
Eligibility Criteria
Inclusion
- Patients previously diagnosed with COVID-19, who required hospitalization and required invasive mechanical ventilation for at least 7 days and who were discharged between August and December 2021 to minimize regression to mean;
- Both sexes;
- Over 18 years old and under 65 years old.
Exclusion
- Need for supplemental home oxygen;
- Motor or neurological or cognitive alteration that contraindicates the participation in the cardiopulmonary rehabilitation program.
- Persistence of clinical signs of deep vein thrombosis
Key Trial Info
Start Date :
June 30 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 23 2023
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT05402007
Start Date
June 30 2022
End Date
March 23 2023
Last Update
July 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro de Fisiatria e Reabilitação da Polícia Militar- RJ
Rio de Janeiro, Rio de Janeiro, Brazil, 21073-460